AAAAAA

   
Results: 1-10 |
Results: 10
Synthesis of potent and selective dopamine D-4 antagonists as candidate radioligands
Authors: Huang, YY Kegeles, LS Bae, SA Hwang, DR Roth, BL Savage, JE Laruelle, M
Citation: Yy. Huang et al., Synthesis of potent and selective dopamine D-4 antagonists as candidate radioligands, BIOORG MED, 11(11), 2001, pp. 1375-1377
Dopamine D-2 receptor availability and amphetamine-induced dopamine release in unipolar depression
Authors: Parsey, RV Oquendo, MA Zea-Ponce, Y Rodenhiser, J Kegeles, LS Pratap, M Cooper, TB Van Heertum, R Mann, JJ Laruelle, M
Citation: Rv. Parsey et al., Dopamine D-2 receptor availability and amphetamine-induced dopamine release in unipolar depression, BIOL PSYCHI, 50(5), 2001, pp. 313-322
Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor - Reply
Authors: Kegeles, LS Laruelle, M Carlsson, A
Citation: Ls. Kegeles et al., Ketamine has equal affinity for NMDA receptors and the high-affinity stateof the dopamine D-2 receptor - Reply, BIOL PSYCHI, 49(11), 2001, pp. 955-957
Decreased regional brain metabolism after ECT
Authors: Nobler, MS Oquendo, MA Kegeles, LS Malone, KM Campbell, C Sackeim, HA Mann, JJ
Citation: Ms. Nobler et al., Decreased regional brain metabolism after ECT, AM J PSYCHI, 158(2), 2001, pp. 305-308
(-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors
Authors: Hwang, DR Kegeles, LS Laruelle, M
Citation: Dr. Hwang et al., (-)-N-[C-11]propyl-norapomorphine: A positron-labeled dopamine agonist forPET imaging of D-2 receptors, NUCL MED BI, 27(6), 2000, pp. 533-539
Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies
Authors: Kegeles, LS Shungu, DC Anjilvel, S Chan, S Ellis, SP Xanthopoulos, E Malaspina, D Gorman, JM Mann, JJ Laruelle, M Kaufmann, CA
Citation: Ls. Kegeles et al., Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies, PSYCH RES-N, 98(3), 2000, pp. 163-175
In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652
Authors: Parsey, RV Kegeles, LS Hwang, DR Simpson, N Abi-Dargham, A Mawlawi, O Slifstein, M Van Heertum, RL Mann, JJ Laruelle, M
Citation: Rv. Parsey et al., In vivo quantification of brain serotonin transporters in humans using [C-11]McN 5652, J NUCL MED, 41(9), 2000, pp. 1465-1477
Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia
Authors: Abi-Dargham, A Rodenhiser, J Printz, D Zea-Ponce, Y Gil, R Kegeles, LS Weiss, R Cooper, TB Mann, JJ Van Heertum, RL Gorman, JM Laruelle, M
Citation: A. Abi-dargham et al., Increased baseline occupancy of D-2 receptors by dopamine in schizophrenia, P NAS US, 97(14), 2000, pp. 8104-8109
Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia
Authors: Kegeles, LS Abi-Dargham, A Zea-Ponce, Y Rodenhiser-Hill, J Mann, JJ Van Heertum, RL Cooper, TB Carlsson, A Laruelle, M
Citation: Ls. Kegeles et al., Modulation of amphetamine-induced striatal dopamine release by ketamine inhumans: Implications for schizophrenia, BIOL PSYCHI, 48(7), 2000, pp. 627-640
Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans
Authors: Kegeles, LS Zea-Ponce, Y Abi-Dargham, A Rodenhiser, J Wang, T Weiss, R Van Heertum, RL Mann, JJ Laruelle, M
Citation: Ls. Kegeles et al., Stability of [I-123]IBZM SPECT measurement of amphetamine-induced striataldopamine release in humans, SYNAPSE, 31(4), 1999, pp. 302-308
Risultati: 1-10 |